The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
S100A4 as a biomarker of resistance to gemcitabine: A secondary analysis of RTOG 9704.
Margaret A. Tempero
No relevant relationships to disclose
Jennifer Moughan
No relevant relationships to disclose
Grace E. Kim
No relevant relationships to disclose
Sanjay Kakar
No relevant relationships to disclose
Teresa S. Hyun
No relevant relationships to disclose
William Regine
No relevant relationships to disclose
Rex B. Mowat
No relevant relationships to disclose
Kevin Charpentier
No relevant relationships to disclose
William Small
No relevant relationships to disclose
Chandan Guha
No relevant relationships to disclose
David K. Chang
No relevant relationships to disclose
Andrew Victor Biankin
No relevant relationships to disclose